). Isofol Medical AB.CorporatePresentation. December 2025. Isofol in short. Oncology-focused biotech company listed on NasdaqStockholm...Currently conducting a phase Ib/II trial in metastatic colorectal cancer, the 3rd most common form of cancer. 3 ... 01 ... 02.
